Life changes and depressive symptoms: the effects of valence and amount of change

نویسندگان

  • Elise C Bennik
  • Johan Ormel
  • Albertine J Oldehinkel
چکیده

BACKGROUND Only few studies have focused on the effects of positive life changes on depression, and the ones that did demonstrated inconsistent findings. The aim of the present study was to obtain a better understanding of the influence of positive life changes on depressive symptoms by decomposing life changes into a valence and an amount of change component. METHODS Using hierarchical multiple regression, we examined the unique effects of valence (pleasantness/unpleasantness) and amount of change on depressive symptoms in 2230 adolescents (M age: 16.28 years) from the TRAILS study. RESULTS Adjusted for age, gender and pre-event depressive symptoms, the amount of life change was positively associated with depressive symptoms. A small excess of positive life changes predicted fewer symptoms, but experiencing a large excess of positive life changes did not have any additional beneficial effects, rather the opposite. Valence was more strongly associated with cognitive-affective than with neurovegetative-somatic symptoms. CONCLUSIONS More positive life changes relative to negative life changes can protect against depressive symptoms, yet only when the amount of change is limited. This study encourages examination of the effects of life changes on specific symptom clusters instead of total numbers of depressive symptoms, which is the current standard.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparing the Effectiveness of Paroxetine, Attention Modification Program and Combination of both on Improving Social Anxiety Symptoms

Introduction: Although the effectiveness of paroxetine and Attention Modification Program has been studied separately in treating social anxiety disorder, there has been no research comparing them according to the literature. The aim of this study was to compare the effectiveness of paroxetine, Attention Modification Program (AMP) and combination of both on improving the Social Anxiety Symptoms...

متن کامل

تأثیر ربوکستین در درمان افسردگی کودکان و نوجوانان: یک مطالعه کلینیکی آینده‌نگر

Background: Depressive disorders in children and adolescents are chronic and highly morbid. Few studies are carried out on antidepressant drugs for depressed youths, especially specific noradrenergic agents. Reboxetine is a selective norepinephrine reuptake inhibitor. This study was designed to evaluate the effect of reboxetine in childhood and adolescent depression. Methods: Twenty patients of...

متن کامل

اثر بخشی درمان گروهی فعال سازی رفتاری در کاهش شدت علایم افسردگی و افزایش سلامت عمومی و کیفیت زندگی مددجویان مرکز اجتماع درمان مدار

introduction: Depression is one of the most common psychological disorders that comorbids with substance use disorders. depression is not only the factor that predisposes persons to abuse substanses but also the factor resulting in relapse. The aim of this study was to determine effectiveness of group behavioral activation treatment in reducing depressive symptoms and effects of this treatment ...

متن کامل

Predictors of Quality of Life in Pregnant Women Visiting Health Centers of Tabriz, Iran

Background & aim: To have successful pregnancy, it is necessary to focus on the mother’s quality of life during pregnancy. This study was conducted to determine the predictors of quality of life among Iranian pregnant women.  Methods: This cross-sectional study was conducted on 565 pregnant women visiting health centers of Tabriz, Iran, 2015. The participants were selected using the cluster sam...

متن کامل

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

Background: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia.Methods: In a double-blinded, placebo-controlled, randomized trial (IRCT registration # 201112125280N7), in ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 1  شماره 

صفحات  -

تاریخ انتشار 2013